20 Results

People

  1. Shoushtari
    Shoushtari
  2. Chapman
    Chapman
  3. Postow
    Postow
  4. Abramson
    Abramson
  5. Callahan
    Callahan
  6. Francis
    Francis
  7. Panageas
    Panageas
  8. Wolchok
    Wolchok
  9. Momtaz
    Momtaz
  10. Barker
    Barker

Groups

  1. Department of Medicine (20)
  2. Hematologic Malignancies, Division of (20)
  3. Melanoma Disease Management Team (20)
  4. Melanoma and Immunotherapeutics Service (20)
  5. Solid Tumor Oncology Division (20)
  6. Population Sciences Research Program (10)
  7. Biostatistics Service (9)
  8. Epidemiology and Biostatistics (9)
  9. GSK Faculty (9)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (8)
  1. "male"
  2. "Alexander Shoushtari"
Formats
  1. Journal Article (20)
Groups
  1. Department of Medicine (20)
  2. Hematologic Malignancies, Division of (20)
  3. Melanoma Disease Management Team (20)
  4. Melanoma and Immunotherapeutics Service (20)
  5. Solid Tumor Oncology Division (20)
  6. Population Sciences Research Program (10)

More Groups

People
  1. Alexander Shoushtari (20)
  2. Paul Chapman (8)
  3. Michael Postow (7)
  4. David Abramson (6)
  5. Margaret Callahan (6)
  6. Jasmine Francis (5)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (4)
  4. 2020 (4)
  5. 2019 (1)
  6. 2018 (2)

More Years

Publications
  1. Annals of Oncology (4)
  2. American Journal of Ophthalmology Case Reports (1)
  3. Annals of Surgical Oncology (1)
  4. British Journal of Cancer (1)
  5. Human Pathology (1)
  6. JAMA Oncology (1)

More Publications

Publishers
  1. Oxford University Press (4)
  2. Elsevier Inc. (3)
  3. Springer (3)
  4. American Medical Association (2)
  5. American Society of Clinical Oncology (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (20)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: A propensity score-weighted analysis
    Journal Article

    Piulats, J. M.; Watkins, C.; Costa-García, M.; del Carpio, L.; Piperno-Neumann, S.; Rutkowski, P.; Hassel, J. C.; Espinosa, E.; de la Cruz-Merino, L.; Ochsenreither, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitors
    Journal Article

    Francis, J. H.; Barker, C. A.; Canestraro, J.; Abramson, D. H.; Shoushtari, A. N.
    American Journal of Ophthalmology Case Reports (2024)

    Fulltext@MSK | Save
  • Beyond the 5-year milestone: Long-term survivorship of melanoma patients treated off-trial with anti-PD-1
    Journal Article

    Loo, K.; Kalvin, H. L.; Panageas, K. S.; Callahan, M. K.; Chapman, P. B.; Momtaz, P.; Shoushtari, A. N.; Wolchok, J. D.; Postow, M. A.; Warner, A. B.
    Pigment Cell & Melanoma Research (2023)

    Fulltext@MSK | Save
  • Clinical and genomic correlates of imatinib response in melanomas with KIT alterations
    Journal Article

    Jung, S.; Armstrong, E.; Wei, A. Z.; Ye, F.; Lee, A.; Carlino, M. S.; Sullivan, R. J.; Carvajal, R. D.; Shoushtari, A. N.; Johnson, D. B.
    British Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: An international, retrospective, cohort study
    Journal Article

    Dimitriou, F.; Namikawa, K.; Reijers, I. L. M.; Buchbinder, E. I.; Soon, J. A.; Zaremba, A.; Teterycz, P.; Mooradian, M. J.; Armstrong, E.; Nakamura, Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Deciphering radiological stable disease to immune checkpoint inhibitors
    Journal Article

    Luo, J.; Wu, S.; Rizvi, H.; Zhang, Q.; Egger, J. V.; Osorio, J. C.; Schoenfeld, A. J.; Plodkowski, A. J.; Ginsberg, M. S.; Callahan, M. K.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Quality of life concerns in patients with uveal melanoma after initial diagnosis
    Journal Article

    Barker, C. A.; Kozlova, A.; Shoushtari, A. N.; Hay, J. L.; Francis, J. H.; Abramson, D. H.
    Ocular Oncology and Pathology (2020)

    Fulltext@MSK | Save
  • Isolated abducens nerve palsy following pembrolizumab
    Journal Article

    Jaben, K. A.; Francis, J. H.; Shoushtari, A. N.; Abramson, D. H.
    Neuro-Ophthalmology (2020)

    Fulltext@MSK | Save
  • Survival outcomes after metastasectomy in melanoma patients categorized by response to checkpoint blockade
    Journal Article

    Bello, D. M.; Panageas, K. S.; Hollmann, T.; Shoushtari, A. N.; Momtaz, P.; Chapman, P. B.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save